1Stavrou P,Good PA,Broadhurst EJ,et al.ERG and EOG abnormalities in carriers of X-linked retinitis pigmentosa[].Eye.1996
2Sandberg MA,Weigel-DiFranco C,Rosner B,et al.The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa[].Investigative Ophthalmology.1996
3Karpe G. The basis of clinical electroretinography [ J ]. Acta Ophthalmol, 1995 ,Suppl:24.
4Ehinger B. Tapetoretinal degenerations : experiences, experiments and expectations [ J ]. Acta Ophthalmol Scand, 2000,78:244-255.
5Sandberg M A, Weigel-DiFranco C, Rosner B, et al. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa [ J ]. Invest Ophthalmol Vis Sci, 1996,37:1693- 1698.
6Marg E, Freeman D N, Pehzman P. Visual acuity development in human infant: Evoked Potentials measurements [ J]. Invest Ophthalmol Vis Sci, 1976,15 : 150-153.
7Liu Q, Saveliev A, Peirce E A. The severity of retinal degeneration in Rplh gene-targeted mice is dependent on genetic background [ J ]. Invest Ophthalmol Vis Sci, 2009, 50 : 1566- 1574.
8Gover S, Fishman G A, Anderson R J, et al. Rate of visual field loss in retinitis pigmentosa[ J]. Ophthalmology, 1997, 104:460-465.
9Grover S, Fishman G A, Brown J, et al. Patterns of visual field progression in patients with retinitis pigmentosa [ J ]. Ophthalmology, 1998,105:1069- 1075.
